Project Grant S10OD038209
- Federal Project Grant Award Summary Wayne State University received a $203,712 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) effective August 15, 2025, with completion scheduled for August 14, 2026. The award supports the acquisition and implementation of an automated liquid chromatography-mass spectrometry (LC-MS) sample preparation system—specifically the Hamilton MassExtract Starlet—for the Wayne...
- Federal Project Grant Award Summary Wayne State University received a $377,400 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a Canopy Biosciences CellScape instrument for high-parameter cellular phenotyping. The award, effective August 1, 2025 through July 31, 2026, supports the purchase and installation of this specialized instrumentation within the university's Microscopy, Imaging, and...
- Federal Project Grant Award Summary The University of Michigan received $155,178 in federal funding under the Research Infrastructure Programs (CFDA 93.351) administered by the National Institutes of Health Office of the Director. The award, dated June 1, 2026, with completion by May 31, 2027, supports the acquisition of a Pherastar FSX multimode high-throughput screening (HTS) microplate reader for the Center for Chemical Genomics (CCG) at the Life Sciences Institute. This equipment purchase...
- Federal Grant Award Summary Michigan State University received $1.81 million in federal funding from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) for the modernization of a 600 megahertz nuclear magnetic resonance (NMR) spectrometer at the Max T. Rogers NMR Facility. The award, issued June 1, 2026, with completion targeted for May 31, 2027, supports the acquisition and installation of a solid-state cross-polarization...
- This Project Grant award of $348,724.00 from the U.S. Department of Health and Human Services National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), will enable Auburn University to acquire a shared Agilent 6546 LC-QTOF (Liquid Chromatography-Quadrupole Time-of-Flight) mass spectrometer. This state-of-the-art instrument will replace an outdated 15-year-old mass spectrometer, significantly enhancing the university's biomedical research capabilities across a...
- Federal Grant Award Summary Jackson State University received a $245,380 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for August 7, 2026. The funding supports the acquisition of a triple quadrupole mass spectrometer to establish the institution's first Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) research capability....
- Federal Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $731,708 to the University of California, Los Angeles under the Research Infrastructure Programs (CFDA 93.351) on June 15, 2026, for a one-year project period concluding June 14, 2027. This Project Grant supports the acquisition and installation of a high-performance 500 megahertz nuclear magnetic resonance (NMR) spectrometer system, including an Avance NEO 500 digital console and broadband...
- Federal Grant Award Summary Michigan Technological University received a $383,801 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) awarded May 1, 2026, with completion scheduled for February 28, 2031. The grant supports the development of a cost-effective, scalable biosensing platform utilizing molecularly imprinted polymers (MIPs)—synthetic receptors that mimic antibody recognition—to enable rapid...
- Federal Grant Award Summary Virginia Commonwealth University (VCU) received a Project Grant award of $489,354 from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a SCIEX Triple Quad 7500 System—QTRAP mass spectrometer for the Virginia Commonwealth University and Massey Comprehensive Cancer Center Lipidomics and Metabolomics Core (VLMC). The award, effective June 1, 2026 through May 31, 2027, supports the...
- Federal Project Grant Award Summary Emory University received a $747,569 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an ultra high-performance liquid chromatograph coupled with a SCIEX triple quadrupole 7500 tandem mass spectrometer (LC-MS/MS) system. The instrument was acquired for installation in the Targeted Analysis Core (TAC) within the Rollins School of Public Health at Emory...
Wayne State University received a $749,967 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on June 15, 2026, with a completion date of June 14, 2027. The award funds the acquisition and installation of a high-throughput solid phase extraction liquid chromatograph triple quadrupole mass spectrometer (HT-SPE-LC-MSMS) at the institution's Lumigen Instrument Center (LIC) in Detroit, Michigan. This state-of-the-art analytical instrument will serve as a shared research resource for the university and regional research community. The HT-SPE-LC-MSMS instrument will address critical infrastructure gaps by significantly increasing the center's targeted mass spectrometry analysis capacity—currently handling over 13,000 analyses annually—while enabling the development of new analytical methods tailored to individual researcher needs. The instrument's capabilities will support diverse analytical applications including cyanotoxin and cyanopeptide analysis, mycotoxin detection, volatile organic compound metabolite profiling, per- and polyfluoroalkyl substance (PFAS) analysis, hormone and endocrine disruptor quantification, drugs of abuse screening, and absorption, distribution, metabolism, and excretion (ADME) studies. By providing the only shared facility instrument on campus with integrated high-throughput online solid phase extraction and targeted analysis capability, the equipment will enhance research productivity for NIH-funded investigators while reducing laboratory sample preparation costs.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $750.0k | 6/11/26 |